Since both human CM and murine ECM show major involvement of CXCL10 in pathogenesis of the disease, it is expected that sequence variations in the CXCL10 gene may result in altered expression of transcriptional and translational products thereby modulating CM progression in malaria patients. This evidence concerns the gene CXCL10 and malaria.